Drugmaker Abbott says not pursuing an offer for St Jude Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
Deutsche Bank Has Mixed View of Hypothetical Abbott Labs (ABT) & St. Jude Medical (STJ) Deal
August 27, 2015 11:42 AM EDTDeutsche Bank analyst Kristen Stewart said she was "somewhat mixed" on a potential Abbott Labs (NYSE: ABT) and St. Jude Medical (NYSE: STJ) deal. Earlier rumors from the Financial Times said Abbott was preparing a $25 billion offer for St. Jude, but the speculation was later denied by Abbott in a statement to Bloomberg. Stewart questioned if buying St. Jude would be the most efficient use of capital.
"We believe that with the addition of STJ, ABT's Medical Device division and more specifically its vascular franchise, would be... More
